Health Catalyst, Inc. — Form 8-K
Filed September 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
Health Catalyst appointed Tami Reller to its board effective October 1, 2026, serving as audit chair and compensation committee member. Reller brings deep healthcare-technology expertise from roles at Microsoft, UnitedHealth Group subsidiaries, and Duly Health and Care (CEO 2022–2023), plus public board experience at SPS Commerce and Avalara. This appointment follows Simeon Kohl's naming as CEO and President effective September 14, 2026, signaling a strategic leadership transition as the company positions itself as an AI-forward healthcare intelligence platform with $2.8 billion in documented outcomes.
Why this rating
Board appointment and CEO confirmation are material governance changes for $259M company, but no M&A, financing, or business impact disclosed yet. Qualified hire suggests strategic reset; wait-and-see on execution.
See more from September 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.